Maureen Testoni

President & CEO of @340BHealth. Passionate about advocating for health providers who care for underserved communities. Also a parent (to young adults & cats.)

[Maureen Testoni @MaureenTestoni]

.@340BHealth members last week visited Capitol Hill to advocate for #340B, which enables safety-net hospitals to offer robust health care services and support to patients most in need.
We are grateful to lawmakers and their staff for their time and the opportunity to share why this lifesaving program must be protected.

[340B Health @340BHealth]

It’s cherry blossom and #340B advocacy season here in Washington, D.C.! We had the privilege of welcoming our members visiting us from more than 28 states, who met with lawmakers and their staff about the need to #Protect340B.

[Maureen Testoni @MaureenTestoni]

Thank you to @RACMonitor for inviting me to speak and write about the biggest change to #340B since it began more than 30 years ago — the effort to turn upfront discounts into backend rebates.

I discussed how this challenge and additional ones could threaten patient care and how the recently introduced bicameral 340B PATIENTS Act could help protect the program: https://t.co/DCrwHYw7VE.

[RACmonitor, A Panacea Solution @RACmonitor]

Big Pharma's under fire and 340B Health is fighting back. 🎯 Join #MonitorMondays live on Aug. 4 to hear from Maureen Testoni + experts reporting on RACs, audits, legislation & more. Don't miss this powerful panel. Register now: https://t.co/Ze4tqg1SAg
#HealthcarePolicy

[Maureen Testoni @MaureenTestoni]

We appreciate @HRSAgov’s commitment to #340B and supporting safety-net hospitals but remain deeply concerned about 340B rebate model plans. @340BHealth’s recent analysis (https://t.co/pYr2jKip4z) shows the financial and administrative burdens rebates will place on hospitals, affecting their ability to deliver critical care services. With our mission to #Protect340B, we will continue working with HRSA so 340B remains strong and sustainable.

[340B Health @340BHealth]

A limited pilot program announced by @HRSAgov would allow some drugmakers to replace upfront #340B discounts with backend rebates. More: https://t.co/xZfQuIRGP9.
The program would apply only to the first 10 Medicare drugs subject to price caps in 2026, but HRSA might expand the program in future years.
While we recognize the agency’s intent to test a limited rebate model tied to #IRA implementation, we remain deeply concerned about the financial and administrative burdens the rebate approach will place on 340B hospitals.
Read our press release: https://t.co/xZfQuIRGP9.

[Maureen Testoni @MaureenTestoni]

@340BHealth members, running off the energy of the #340BConf, took their knowledge and passion straight to Capitol Hill.

Armed with fresh insights and a renewed sense of purpose, they met with congressional staff to share how low-income and rural patients across the country are supported #Becauseof340B.

Thank you to all our members who stepped up and made their voices heard!

[340B Health @340BHealth]

We are proud to support federal legislation that would #Protect340B covered entities from drugmaker conditions on pharmacy partnerships.

Congresswoman @DorisMatsui and @SenPeterWelch introduced the 340B PATIENTS Act earlier this week.

Many of our hospital members, equipped with fresh insights from the @340BCoalition #340BConf, are on Capitol Hill meeting with congressional staff and raising awareness about this legislation and other ways to protect the program.

We commend their commitment to their communities and their patients whose lives are healthier and better #Becauseof340B.

[Maureen Testoni @MaureenTestoni]

@340BHealth members, running off the energy of the #340BConf, took their knowledge and passion straight to Capitol Hill last week.

Armed with fresh insights and a renewed sense of purpose, they met with congressional staff to share how low-income and rural patients across the country are supported #Becauseof340B.

Thank you to all our members who stepped up and made their voices heard!

[340B Health @340BHealth]

We are proud to support federal legislation that would #Protect340B covered entities from drugmaker conditions on pharmacy partnerships.

Congresswoman @DorisMatsui and @SenPeterWelch introduced the 340B PATIENTS Act earlier this week.

Many of our hospital members, equipped with fresh insights from the @340BCoalition #340BConf, are on Capitol Hill meeting with congressional staff and raising awareness about this legislation and other ways to protect the program.

We commend their commitment to their communities and their patients whose lives are healthier and better #Becauseof340B.

[Maureen Testoni @MaureenTestoni]

I thank everyone who made the @340BCoalition #340BConf possible—our speakers, attendees, sponsors, and staff.

Your commitment to advancing 340B care for disadvantaged communities is inspiring!

The challenges ahead are real, but so is our strength when we stay united, informed, and engaged.

Let’s carry this momentum forward.

[340B Health @340BHealth]

Despite drugmaker restrictions, federal funding cuts, and other challenges, the #340B community at this #340BConf showed up and stood united in the spirit of education, connection, and advocacy.

Through session programming, informative keynotes, and essential networking opportunities, attendees left equipped with the knowledge and connections to #Protect340B from any threats that come our way.

Thank you to our @340BCoalition partners for helping us make this conference an unforgettable one!

[Maureen Testoni @MaureenTestoni]

Policy changes, funding threats, and drugmaker overreach put #340B at risk—but providers don’t have to face it alone. At next week’s @340BCoalition #340BConf, join the community to learn, connect, and protect care for those who need it most.

[Maureen Testoni @MaureenTestoni]

As health care spending in the U.S. continues to climb, it’s more important than ever to #Protect340B.
In 2033, U.S. households, businesses, and governments are expected to spend $8.6 trillion on health care. #340B is vital because it redirects a small portion of pharmaceutical profits back into the health care safety net. 340B is a lifeline for so many providers and patients—we must maintain and strengthen it.

[Modern Healthcare @modrnhealthcr]

US health spending projected to hit $8.6T by 2033 https://t.co/mr5bW4ySqC

[340B Health @340BHealth]

The @340BCoalition Summer #340BConf, occurring July 21-23 just a few miles away from the nation’s capital, will feature keynotes from drug pricing and policy experts @MaureenTestoni, Chantelle Britton of OPA, and Amy Walter of "The Cook Political Report with Amy Walter." Register now to hear their insights, learn alongside the #340B community, and network with the 340B community: https://t.co/RBYv8LNr7a.

[Maureen Testoni @MaureenTestoni]

Thrilled to be speaking at the #HFMAAnnual Conference! Join me as we explore ways to Lead the Way in health care finance. Attend the session titled “340B Hospitals: Navigating Financial and Operational Impacts” to connect, learn, and shape the future together. See you there! https://t.co/fZLNtqjgfM

[Maureen Testoni @MaureenTestoni]

.@340BHealth's newly elected members bring two decades of clinical pharmacy and health system leadership experience to our board of directors. We welcome their invaluable contributions during this crucial time for #340B. Please join us in welcoming Elie Bahou (@Providence) and Damon Redding (@trinityhealthmi) onboard! Read our announcement: https://t.co/uEsftI6m99.

[Maureen Testoni @MaureenTestoni]

Another key win: a second federal judge has allowed @340BHealth and member hospitals to intervene in the @JNJNews rebate lawsuit. This ensures we remain closely involved in the fight to block harmful rebate schemes that would burden #340B hospitals. #Protect340B

[340B Health @340BHealth]

#340B hospitals are a big part of the fight to #Protect340B from rebate schemes!

Last week, a federal judge granted our motion to intervene in @JNJNews’ lawsuit over the gov’s refusal to approve the company’s rebate scheme.

Alongside @GenesisHCS and @umassmemorial, we’ll have yet another opportunity to go to court and represent all 340B hospitals, which stand to experience severe financial harm if rebates proceed.

[Maureen Testoni @MaureenTestoni]

A federal judge rejected the ability of four drugmakers and an industry consultant to unilaterally replace upfront #340B discounts with backend rebates.

@GenesisHCS and @umassmemorial joined @340BHealth in court to oppose rebates and demonstrate the immense harm unilateral drugmaker rebate schemes would cause safety-net hospitals and the patients they serve.

Read our statement for more: https://t.co/IvmKNs8hX9. #Protect340B

[340B Health @340BHealth]

A federal judge rejected the ability of four drugmakers and an industry consultant to unilaterally replace upfront #340B discounts with backend rebates. Our official statement: https://t.co/8YGne5AqdK.

Having intervened as defendants in this case, we successfully argued that rebates would subject hospitals to immense financial harm, and we are pleased the opinion recognizes this.

We, alongside @GenesisHCS and @umassmemorial, look forward to continuing to #Protect340B against such rebate schemes.

[Maureen Testoni @MaureenTestoni]

A recent trend in @BeckersHR’s reporting highlights anxiety among C-suite hospital leaders. The potential for changes to #340B amid grim financial forecasts and sweeping changes at the federal level adds to the uncertainty. We hear these concerns and are advocating for protecting the resources these hospitals need to serve their patients.

[Maureen Testoni @MaureenTestoni]

I’m happy to rejoin #340BInsight, which is in its fifth season and just marked its 70,000th download! Tune in today: https://t.co/zke7GtH3kb.

I discuss major events in #340B, including developments in rebate litigation, potential federal oversight change, a congressional 340B report, and the great strides that states are making to #Protect340B.

[340B Health @340BHealth]

We invited our President and CEO @MaureenTestoni onto #340BInsight for help understanding the litigation around #340B rebate models and potential federal regulatory shifts ahead for 340B. We also discuss how states are responding to the pharmaceutical industry’s efforts to shrink 340B. Catch all that and more on our latest episode: https://t.co/W8IWecvH0k.

[Maureen Testoni @MaureenTestoni]

We appreciate the interest Senator Cassidy has in #340B and the effort the Senate HELP Committee is putting into understanding its complexities. We have some major concerns about the recent report and look forward to educating lawmakers about them.

I recently discussed this on @RACmonitor Monday's, starting at the 21:46 mark in the video linked below.

Read @340BHealth’s statement for more: https://t.co/TY4MjUPARh. #Protect340B

[RACmonitor, A Panacea Solution @RACmonitor]

🎙️ 340B in the Crosshairs — Don't miss the next Monitor Mondays live podcast, May 5!
Maureen Testoni, JD responds to Senator Cassidy's 340B report—plus other panelists tackle audits, policy updates, and compliance risks.
🔴 Tune in live: https://t.co/n9d1GC2JKd

[Maureen Testoni @MaureenTestoni]

Today, @340BHealth participated in oral arguments defending against drugmaker #340B rebate schemes. We are joined by two members who, like many hospitals and health systems, have calculated tremendous financial costs and administrative burdens if rebates are allowed to take effect. #Protect340B

[340B Health @340BHealth]

The #340B statute requires discounts at the point of sale, not as a rebate. This process is not only what has been in place for more than 30 years, but it’s also the most effective way for drugmakers to fulfill their obligation to the health care safety net.

We’re grateful for the opportunity to defend these arguments tomorrow alongside our members @GenesisHCS and @UMassMemorial on behalf of the safety-net providers who face harm from rebates. #Protect340B

[Maureen Testoni @MaureenTestoni]

#340B hospitals care for more patients experiencing higher rates of poverty, unemployment, and housing insecurity than their non-340B counterparts. New research shows safety-net hospitals play a critical role in providing access for uninsured patients and those living with low incomes. Learn more: https://t.co/reqUjIkO3R. #Protect340B

[Maureen Testoni @MaureenTestoni]

I am proud of the #340B providers in Utah, North Dakota, South Dakota, and Nebraska, who recently joined the eight other states with laws on the books that prevent drugmakers from restricting or cutting hospitals’ access to #340B pharmacy partnerships. Advocacy works!

[340B Health @340BHealth]

We welcome #Nebraska to the group of states that have enacted laws protecting #340B pharmacy partnerships for all covered entities — now 12 states and growing! Providers and lawmakers are scoring wins in the fight to #Protect340B against Big Pharma’s efforts to cut the program.